• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

驱动蛋白家族成员15(KIF15)通过促进增殖、抑制凋亡促进胃癌发生,并预示预后不良。

KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis.

作者信息

Ding Lixian, Li Bin, Yu Xiaotong, Li Zhongsheng, Li Xinglong, Dang Shuwei, Lv Qiang, Wei Jiufeng, Sun Haixia, Chen Hongsheng, Liu Ming, Li Guodong

机构信息

1Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, No. 37 Yiyuan Street, Nangang District, Harbin, 150001 Heilongjiang China.

2Bio-Bank of Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, No. 37 Yiyuan Street, Nangang District, Harbin, 150001 Heilongjiang China.

出版信息

Cancer Cell Int. 2020 Apr 15;20:125. doi: 10.1186/s12935-020-01199-7. eCollection 2020.

DOI:10.1186/s12935-020-01199-7
PMID:32322172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7160940/
Abstract

BACKGROUND

Kinesin superfamily proteins (KIFs) can transport membranous organelles and protein complexes in an ATP-dependent manner. Kinesin family member 15 (KIF15) is overexpressed in various cancers. However, the function of KIF15 in gastric cancer (GC) is still unclear.

METHODS

GC patients' data from The Cancer Genome Atlas (TCGA) were analyzed by bioinformatics methods. The expression of KIF15 was examined in GC and paracarcinoma tissues from 41 patients to verify the analysis results. The relationship between KIF15 expression and clinical characteristics were also observed by bioinformatics methods. Kaplan-Meier survival analysis of 122 GC patients in our hospital was performed to explore the relationship between KIF15 expression levels and GC patients' prognosis. KIF15 was downregulated in GC cell lines AGS and SGC-7901 by transfecting a lentivirus-mediated shRNA plasmid targeting KIF15. In vitro, GC cell proliferation and apoptosis were detected by MTT assay, colony formation assay, and Annexin V-APC staining. In vivo, xenograft experiments were used to verify the in vitro results. Furthermore, Human Apoptosis Antibody Array kit was used to screen possible targets of KIF15 in GC cell lines.

RESULTS

The bioinformatics results showed that KIF15 expression levels were higher in GC tissues than in normal tissues. IHC showed same results. High expression of KIF15 was statistical correlated with high age and early histologic stage. Kaplan-Meier curves indicated that high KIF15 expression predict poor prognosis in patients with GC. MTT assay and colony formation assay showed that KIF15 promote GC cell proliferation. Annexin V-APC staining found that KIF15 can inhibit GC cell apoptosis. Xenograft experiments reveal that downregulating KIF15 can inhibit GC tumor growth and promote GC apoptosis. Through detection of 43 anti-apoptotic proteins by the Human Apoptosis Antibody Array kit, it was confirmed that knocking down KIF15 can reduce seven anti-apoptotic proteins expression.

CONCLUSIONS

Taken together, our study revealed a critical role for KIF15 to inhibit GC cell apoptosis and promote GC cell proliferation. KIF15 may decrease anti-apoptotic proteins expression by regulating apoptosis pathways. High expression of KIF15 predicts a poor prognosis in patients with GC. KIF15 might be a novel prognostic biomarker and a therapeutic target for GC.

摘要

背景

驱动蛋白超家族蛋白(KIFs)能够以ATP依赖的方式转运膜性细胞器和蛋白质复合物。驱动蛋白家族成员15(KIF15)在多种癌症中过表达。然而,KIF15在胃癌(GC)中的功能仍不清楚。

方法

采用生物信息学方法分析来自癌症基因组图谱(TCGA)的GC患者数据。检测41例患者GC组织和癌旁组织中KIF15的表达,以验证分析结果。还通过生物信息学方法观察KIF15表达与临床特征之间的关系。对我院122例GC患者进行Kaplan-Meier生存分析,以探讨KIF15表达水平与GC患者预后的关系。通过转染靶向KIF15的慢病毒介导的shRNA质粒,在GC细胞系AGS和SGC-7901中下调KIF15。在体外,通过MTT法、集落形成试验和Annexin V-APC染色检测GC细胞增殖和凋亡。在体内,采用异种移植实验验证体外结果。此外,使用人凋亡抗体阵列试剂盒筛选GC细胞系中KIF15可能的靶点。

结果

生物信息学结果显示,GC组织中KIF15表达水平高于正常组织。免疫组化显示相同结果。KIF15的高表达与高龄和早期组织学分期具有统计学相关性。Kaplan-Meier曲线表明,KIF15高表达预示GC患者预后不良。MTT法和集落形成试验表明,KIF15促进GC细胞增殖。Annexin V-APC染色发现,KIF15可抑制GC细胞凋亡。异种移植实验表明,下调KIF15可抑制GC肿瘤生长并促进GC凋亡。通过人凋亡抗体阵列试剂盒检测43种抗凋亡蛋白,证实敲低KIF15可降低7种抗凋亡蛋白的表达。

结论

综上所述,我们的研究揭示了KIF15在抑制GC细胞凋亡和促进GC细胞增殖中的关键作用。KIF15可能通过调节凋亡途径降低抗凋亡蛋白的表达。KIF15高表达预示GC患者预后不良。KIF15可能是GC的一种新型预后生物标志物和治疗靶点。

相似文献

1
KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis.驱动蛋白家族成员15(KIF15)通过促进增殖、抑制凋亡促进胃癌发生,并预示预后不良。
Cancer Cell Int. 2020 Apr 15;20:125. doi: 10.1186/s12935-020-01199-7. eCollection 2020.
2
KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.KIF15 通过抑制活性氧介导的细胞凋亡促进胃癌细胞的演进。
J Cell Physiol. 2020 Dec;235(12):9388-9398. doi: 10.1002/jcp.29743. Epub 2020 Apr 27.
3
Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.敲低激酶家族 15 抑制体外癌细胞增殖及其在三阴性乳腺癌中的临床相关性。
Curr Mol Med. 2019;19(2):147-155. doi: 10.2174/1566524019666190308122108.
4
KIF15 plays a role in promoting the tumorigenicity of melanoma.KIF15 在促进黑色素瘤的肿瘤发生中发挥作用。
Exp Eye Res. 2019 Aug;185:107598. doi: 10.1016/j.exer.2019.02.014. Epub 2019 Feb 21.
5
Knockdown of Kinesin Family 15 Inhibits Osteosarcoma through Suppressing Cell Proliferation and Promoting Cell Apoptosis.敲低驱动蛋白家族 15 抑制骨肉瘤通过抑制细胞增殖和促进细胞凋亡。
Chemotherapy. 2019;64(4):187-196. doi: 10.1159/000505014. Epub 2020 Feb 19.
6
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.KIF15表达增加预示肺腺癌患者预后不良。
Cell Physiol Biochem. 2018;51(1):1-10. doi: 10.1159/000495155. Epub 2018 Nov 15.
7
Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.前列腺干细胞抗原(PSCA)的下调促进胃癌增殖并与不良预后相关。
J Cancer. 2020 Feb 19;11(9):2708-2715. doi: 10.7150/jca.33575. eCollection 2020.
8
Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma.鉴定 KIF15 作为一种潜在的治疗靶点和神经胶质瘤的预后因素。
Oncol Rep. 2020 Apr;43(4):1035-1044. doi: 10.3892/or.2020.7510. Epub 2020 Feb 21.
9
Combined Inhibition of KIF11 and KIF15 as an Effective Therapeutic Strategy for Gastric Cancer.联合抑制 KIF11 和 KIF15 作为治疗胃癌的有效策略。
Curr Cancer Drug Targets. 2023;23(4):293-306. doi: 10.2174/1568009622666220616122846.
10
Kinesin family member 15 can promote the proliferation of glioblastoma.驱动蛋白家族成员 15 能够促进脑胶质瘤的增殖。
Math Biosci Eng. 2022 Jun 6;19(8):8259-8272. doi: 10.3934/mbe.2022384.

引用本文的文献

1
Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer.集成机器学习算法鉴定 KIF15 为三阴性乳腺癌的一个潜在预后生物标志物,并与干性相关。
Sci Rep. 2024 Sep 13;14(1):21449. doi: 10.1038/s41598-024-72406-y.
2
Kinesin 26B modulates M2 polarization of macrophage by activating cancer-associated fibroblasts to aggravate gastric cancer occurrence and metastasis.驱动蛋白 26B 通过激活癌相关成纤维细胞来调节巨噬细胞 M2 极化,从而加重胃癌的发生和转移。
World J Gastroenterol. 2024 May 28;30(20):2689-2708. doi: 10.3748/wjg.v30.i20.2689.
3

本文引用的文献

1
The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy.细胞外囊泡在胃癌发展、微环境、抗癌药物耐药性和治疗中的作用。
Mol Cancer. 2019 Mar 30;18(1):62. doi: 10.1186/s12943-019-0967-5.
2
KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway.驱动蛋白家族成员15通过丝裂原活化蛋白激酶激酶-细胞外信号调节激酶信号通路促进膀胱癌增殖。
Cancer Manag Res. 2019 Feb 26;11:1857-1868. doi: 10.2147/CMAR.S191681. eCollection 2019.
3
Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis.
KIF15 错义变异与特发性肺纤维化的早发性发病有关。
Respir Res. 2023 Sep 30;24(1):240. doi: 10.1186/s12931-023-02540-0.
4
Knockdown of KIF15 suppresses proliferation of prostate cancer cells and induces apoptosis through PI3K/Akt signaling pathway.敲低KIF15可抑制前列腺癌细胞的增殖,并通过PI3K/Akt信号通路诱导细胞凋亡。
Cell Death Discov. 2023 Sep 1;9(1):326. doi: 10.1038/s41420-023-01625-5.
5
Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.驱动蛋白超家族成员15基因敲低抑制鼻咽癌的细胞增殖、迁移和侵袭。
Korean J Physiol Pharmacol. 2023 Sep 1;27(5):457-470. doi: 10.4196/kjpp.2023.27.5.457.
6
Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer.多胺代谢模式可表征结直肠癌的肿瘤微环境、预后及对免疫治疗的反应。
Cancer Cell Int. 2023 May 18;23(1):96. doi: 10.1186/s12935-023-02892-z.
7
PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.PSMD12 通过上调 KIF15 促进 MEK-ERK 通路的激活,从而促进肝癌的恶性进展。
Cancer Biol Ther. 2022 Dec 31;23(1):1-11. doi: 10.1080/15384047.2022.2125260.
8
Rare and Common Variants in Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis.罕见和常见变异与特发性肺纤维化的遗传风险有关。
Am J Respir Crit Care Med. 2022 Jul 1;206(1):56-69. doi: 10.1164/rccm.202110-2439OC.
9
Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma.KIF15的综合泛癌分析揭示了其在鼻咽癌中的诊断和预后价值。
Front Oncol. 2022 Mar 11;12:772816. doi: 10.3389/fonc.2022.772816. eCollection 2022.
10
Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 Inhibitors in a Gastric Adenocarcinoma In Vitro Model.变构驱动蛋白 Eg5 抑制剂在体外胃腺癌模型中对血管生成级联的负调控。
Molecules. 2022 Jan 31;27(3):957. doi: 10.3390/molecules27030957.
敲低激酶家族 15 抑制体外癌细胞增殖及其在三阴性乳腺癌中的临床相关性。
Curr Mol Med. 2019;19(2):147-155. doi: 10.2174/1566524019666190308122108.
4
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
5
Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients.用于术前预测胃癌患者总生存期的预后特征的开发与验证
Onco Targets Ther. 2018 Dec 4;11:8711-8722. doi: 10.2147/OTT.S181741. eCollection 2018.
6
Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches.胃癌干细胞:机制与治疗方法
Yonsei Med J. 2018 Dec;59(10):1150-1158. doi: 10.3349/ymj.2018.59.10.1150.
7
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.KIF15表达增加预示肺腺癌患者预后不良。
Cell Physiol Biochem. 2018;51(1):1-10. doi: 10.1159/000495155. Epub 2018 Nov 15.
8
Dual targeting of survivin and X-linked inhibitor of apoptosis protein suppresses the growth and promotes the apoptosis of gastric cancer HGC-27 cells.对生存素和X连锁凋亡抑制蛋白的双重靶向作用可抑制胃癌HGC - 27细胞的生长并促进其凋亡。
Oncol Lett. 2018 Sep;16(3):3489-3498. doi: 10.3892/ol.2018.9081. Epub 2018 Jul 5.
9
KIF15 nanomechanics and kinesin inhibitors, with implications for cancer chemotherapeutics.KIF15 的纳米力学和驱动蛋白抑制剂,对癌症化疗有影响。
Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4613-E4622. doi: 10.1073/pnas.1801242115. Epub 2018 Apr 27.
10
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth.ASTX660,一种新型的 cIAP1/2 和 XIAP 的非肽模拟物拮抗剂,可强效诱导肿瘤细胞系中 TNFα 依赖性凋亡并抑制肿瘤生长。
Mol Cancer Ther. 2018 Jul;17(7):1381-1391. doi: 10.1158/1535-7163.MCT-17-0848. Epub 2018 Apr 25.